{"id":913,"date":"2025-02-12T23:29:09","date_gmt":"2025-02-12T23:29:09","guid":{"rendered":"http:\/\/socmexfito.org\/?p=913"},"modified":"2025-02-12T23:29:09","modified_gmt":"2025-02-12T23:29:09","slug":"the-anti-b-titre-showed-an-association-with-gender-0","status":"publish","type":"post","link":"https:\/\/socmexfito.org\/?p=913","title":{"rendered":"\ufeffThe anti-B titre showed an association with gender (< 0"},"content":{"rendered":"

\ufeffThe anti-B titre showed an association with gender (< 0.001), and was high in woman donors (77.8%). experienced higher anti-A and anti-B titres. The anti-B titre showed an association with gender (< 0.001), and was high in woman donors (77.8%). Males aged over 50 years old were found to have low imply titre antibodies. Most donors experienced both IgM and IgG ABO antibodies. The prevalence of haemolysins in our human population was 3.5%. Summary Most of our O blood donors had a high ABO antibody titre but a low prevalence of Histone Acetyltransferase Inhibitor II haemolysins. Males aged over 50 years old are the best O donors for avoiding Histone Acetyltransferase Inhibitor II HTRs, particularly when mismatch transfusion is required. We recommend a transfusion unit display for ABO antibody titre in more youthful female donors (< 40 years older), to prevent the transfusion of high titre O blood products into non-O recipients. Keywords: anti-A, anti-B, antibody titres, haemolytic transfusion reaction, O group, haemolysin Intro In Malaysia, the Malays and Chinese have the highest percentage of blood Group O (36.7%). Among Indians, O and B blood groups were found at equal frequencies (1). Blood Histone Acetyltransferase Inhibitor II<\/a> Group O is well known as the common blood group because its reddish cells lack A and B antigens (2). Therefore, it is widely accepted as safe to transfuse Group O reddish cells to non-O group recipients, particularly in life-saving conditions (3). However, its plasma consists of anti-A and anti-B antibodies of the immunoglobulin M (IgM) type. A small proportion of these antibodies can be IgG or IgA. Both ABO IgM and IgG antibodies can activate match and result in intravascular haemolysis (4). These may occur following a transfer of ABO antibodies into non-O recipients, such as in ABO-incompatible platelet transfusions (5). ABO antibodies begin to become produced at birth, even though titre is typically too low for detection. The titre levels are variable, depending on gender, age and environmental factors. Among blood Group O donors, anti-A titres are frequently reported to be greater than anti-B titres (6). The ABO IgM antibody titre 64 has been agreed upon in many works of literature as high, whereas the high titre for IgG antibodies is definitely 200 (7C9). During the Vietnam War, the United States military force used whole-blood products having a titre of < 256 to treat haemorrhagic shock (10). In the United Kingdom, antibody titration is required for those O group donors, with ABO antibody titres > 100 deemed as high and permitting transfusion to only O blood group individuals (7). Standard recommendations for defining the high titre of ABO antibodies are lacking in the transfusion community. For both ABO IgM and IgG antibodies, our study used a cut-off titre value of 64 as a high titre. This cut-off point was selected considering other studies that used a similar cut-off titre in their study (7, 11). This study aimed to estimate the prevalence of the high titre of ABO antibodies among O blood donors in our local human population and its association with gender and age. We also targeted to determine the type of Igs of anti-A and anti-B antibodies, either IgM only or a combination of IgM and IgG types. Moreover, we intended to determine the prevalence of a high IgG titre and haemolysin antibodies among our Group O blood donors. The Group O blood product is definitely widely used in medical transfusion practice. Thus, we hope the findings of this study contribute to safe transfusion methods. To the best of our knowledge, no similar study offers been performed on our local human population. Methods Study Establishing The study was conducted in the Transfusion Medicine Unit of Hospital Universiti Sains Malaysia from January to December 2020. The study protocol was authorized by the Institutional Review Table of the Human being Study Ethics Committee. Study Human population A total of 311 samples were collected randomly from whole-blood Group O donors, from 18 years old to 60 years older of age. All selected donors fulfilled the pre-donation criteria according to the national recommendations for donor selections. Samples and Reagents About 3 mL of blood was collected Rabbit Polyclonal to hnRNP L<\/a> into an ethylene-diamine-tetra acetic acid tube. The sample was stored in a 4 CC6 C fridge and analysed less than 48 h after collection. In-house preparations of 3% concentrated A1 cells and B cells were utilized for titre studies, and Ig and haemolysis checks. To cleave pentameric IgM disulphide bonds, 0.01 M dithiothreitol (DTT) (Sigma-Aldrich D9163) was used. DTT eliminated the agglutinating reactivity of IgM and permitted the detection of IgG antibodies in the.<\/p>\n","protected":false},"excerpt":{"rendered":"

\ufeffThe anti-B titre showed an association with gender (< 0.001), and was high in woman donors (77.8%). experienced higher anti-A and anti-B titres. The anti-B titre showed an association with gender (< 0.001), and was high in woman donors (77.8%). Males aged over 50 years old were found to have low imply titre antibodies. Most donors experienced both IgM and IgG ABO antibodies. The prevalence of haemolysins in our human population was 3.5%. Summary Most of our O blood donors had a high ABO antibody titre but a low prevalence of Histone Acetyltransferase Inhibitor II haemolysins. Males aged over 50 years old are the best O donors for avoiding Histone Acetyltransferase Inhibitor II HTRs, particularly when mismatch transfusion is required. We recommend a transfusion unit display for ABO antibody titre in more youthful female donors (< 40 years older), to prevent the transfusion of high titre O blood products into non-O recipients. Keywords: anti-A, anti-B, antibody titres, haemolytic transfusion reaction, O group, haemolysin Intro In Malaysia, the Malays and Chinese have the highest percentage of blood Group O (36.7%). Among Indians, O and B blood groups were found at equal frequencies (1). Blood Histone Acetyltransferase Inhibitor II Group O is well known as the common blood group because its reddish cells lack A and B antigens (2). Therefore, it is widely accepted as safe to transfuse Group O reddish cells to non-O group recipients, particularly in life-saving conditions (3). However, its plasma consists of anti-A and anti-B antibodies of the immunoglobulin M (IgM) type. A small proportion of these antibodies can be IgG or IgA. Both ABO IgM and IgG antibodies can activate match and result in intravascular haemolysis (4). These may occur following a transfer of ABO antibodies into non-O recipients, such as in ABO-incompatible platelet transfusions (5). ABO antibodies begin to become produced at birth, even though titre is typically too low for detection. The titre levels are variable, depending on gender, age and environmental factors. Among blood Group O donors, anti-A titres are frequently reported to be greater than anti-B titres (6). The ABO IgM antibody titre 64 has been agreed upon in many works of literature as high, whereas the high titre for IgG antibodies is definitely 200 (7C9). During the Vietnam War, the United States military force used whole-blood products having a titre of < 256 to treat haemorrhagic shock (10). In the United Kingdom, antibody titration is required for those O group donors, with ABO antibody titres > 100 deemed as high and permitting transfusion to only O blood group individuals (7). Standard recommendations for defining the high titre of ABO antibodies are lacking in the transfusion community. For both ABO IgM and IgG antibodies, our study used a cut-off titre value of 64 as a high titre. This cut-off point was selected considering other studies that used a similar cut-off titre in their study (7, 11). This study aimed to estimate the prevalence of the high titre of ABO antibodies among O blood donors in our local human population and its association with gender and age. We also targeted to determine the type of Igs of anti-A and anti-B antibodies, either IgM only or a combination of IgM and IgG types. Moreover, we intended to determine the prevalence of a high IgG titre and haemolysin antibodies among our Group O blood donors. The Group O blood product is definitely widely used in medical transfusion practice. Thus, we hope the findings of this study contribute to safe transfusion methods. To the best of our knowledge, no similar study offers been performed on our local human population. Methods Study Establishing The study was conducted in the Transfusion Medicine Unit of Hospital Universiti Sains Malaysia from January to December 2020. The study protocol was authorized by the Institutional Review Table of the Human being Study Ethics Committee. Study Human population A total of 311 samples were collected randomly from whole-blood Group O donors, from 18 years old to 60 years older of age. All selected donors fulfilled the pre-donation criteria according to the national recommendations for donor selections. Samples and Reagents About 3 mL of blood was collected Rabbit Polyclonal to hnRNP L into an ethylene-diamine-tetra acetic acid tube. The sample was stored in a 4 CC6 C fridge and analysed less than 48 h after collection. In-house preparations of 3% concentrated A1 cells and B cells were utilized for titre studies, and Ig and haemolysis checks. To cleave pentameric IgM disulphide bonds, 0.01 M dithiothreitol (DTT) (Sigma-Aldrich D9163) was used. DTT eliminated the agglutinating reactivity of IgM and permitted the detection of IgG antibodies in the.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[],"class_list":["post-913","post","type-post","status-publish","format-standard","hentry","category-mglu2-receptors"],"_links":{"self":[{"href":"https:\/\/socmexfito.org\/index.php?rest_route=\/wp\/v2\/posts\/913","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/socmexfito.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/socmexfito.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/socmexfito.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/socmexfito.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=913"}],"version-history":[{"count":1,"href":"https:\/\/socmexfito.org\/index.php?rest_route=\/wp\/v2\/posts\/913\/revisions"}],"predecessor-version":[{"id":914,"href":"https:\/\/socmexfito.org\/index.php?rest_route=\/wp\/v2\/posts\/913\/revisions\/914"}],"wp:attachment":[{"href":"https:\/\/socmexfito.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=913"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/socmexfito.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=913"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/socmexfito.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=913"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}